Institutional & Family Asset Management, LLC Eli Lilly & CO Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

A detailed history of Institutional & Family Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Institutional & Family Asset Management, LLC holds 6,502 shares of LLY stock, worth $5.17 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

6,502

Previous 6,993 7.02%

Holding current value

$5.17 Million

Previous $5.44 Million 8.2%

% of portfolio

0.7%

Previous 0.66%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 05, 2024	SELL	$724.87 - $909.04 $355,911 - $446,338	-491 Reduced 7.02%	6,502 $5.89 Million
Q1 2024 May 08, 2024	SELL	$592.2 - $792.28 $1.22 Million - $1.64 Million	-2,067 Reduced 22.81%	6,993 $5.44 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $345,049 - $406,768	-657 Reduced 6.76%	9,060 $5.28 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $1.03 Million - $1.42 Million	-2,373 Reduced 19.63%	9,717 $5.22 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $616,951 - $824,935	-1,759 Reduced 12.7%	12,090 $5.67 Million
Q1 2023 May 08, 2023	BUY	$310.63 - $364.82 $86,976 - $102,149	280 Added 2.06%	13,849 $4.76 Million
Q4 2022 Feb 08, 2023	SELL	$321.55 - $374.67 $599,369 - $698,384	-1,864 Reduced 12.08%	13,569 $4.96 Million
Q3 2022 Nov 07, 2022	BUY	$296.48 - $337.87 $37,652 - $42,909	127 Added 0.83%	15,433 $4.99 Million
Q2 2022 Aug 08, 2022	BUY	$278.73 - $327.27 $67,173 - $78,872	241 Added 1.6%	15,306 $4.96 Million
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $37,315 - $46,373	159 Added 1.07%	15,065 $4.31 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $377,073 - $467,950	-1,677 Reduced 10.11%	14,906 $4.12 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $517,436 - $636,777	-2,335 Reduced 12.34%	16,583 $3.83 Million
Q2 2021 Aug 10, 2021	BUY	$180.55 - $233.54 $463,110 - $599,030	2,565 Added 15.69%	18,918 $4.34 Million
Q1 2021 May 06, 2021	SELL	$164.32 - $212.72 $170,235 - $220,377	-1,036 Reduced 5.96%	16,353 $3.06 Million
Q4 2020 Feb 03, 2021	SELL	$130.46 - $172.63 $47,356 - $62,664	-363 Reduced 2.04%	17,389 $2.94 Million
Q3 2020 Oct 30, 2020	SELL	$146.22 - $169.13 $300,189 - $347,223	-2,053 Reduced 10.37%	17,752 $2.63 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $131,236 - $157,941	-962 Reduced 4.63%	19,805 $3.25 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $306,434 - $379,278	-2,574 Reduced 11.03%	20,767 $2.88 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $323,646 - $400,865	-3,027 Reduced 11.48%	23,341 $3.07 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $9,290 - $10,105	-87 Reduced 0.33%	26,368 $2.95 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $84,865 - $99,059	766 Added 2.98%	26,455 $2.93 Million
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $194,347 - $228,760	-1,746 Reduced 6.36%	25,689 $3.33 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $1.02 Million - $1.14 Million	-9,598 Reduced 25.92%	27,435 $3.18 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $83,541 - $104,412	-973 Reduced 2.56%	37,033 $3.97 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $308,023 - $353,514	-4,069 Reduced 9.67%	38,006 $3.24 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $571,194 - $674,257	-7,697 Reduced 15.46%	42,075 $3.26 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $280,480 - $300,847	3,423 Added 7.39%	49,772 $4.2 Million
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $103,119 - $114,452	-1,338 Reduced 2.81%	46,349 $3.97 Million
Q2 2017 Aug 14, 2017	BUY	N/A	47,687	47,687 $3.93 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account

Institutional & Family Asset Management, LLC Eli Lilly & CO Transaction History